Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001890784-25-000005

Chief Accounting Officer acquired 26,680 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anand Bhaskar Chief Accounting Officer 2025-10-21 Grant or award +26,680 $18.74 $499,983 159,751 D: show line 1 in the form
Loading xslF345X05/wk-form4_1761250310.xml…